Difference between revisions of "Team:Queens Canada/Circ AFP"
(2 intermediate revisions by the same user not shown) | |||
Line 57: | Line 57: | ||
<h2>Design & Cloning</h2> | <h2>Design & Cloning</h2> | ||
− | <p>A thorough dry lab analysis was performed to determine the appropriate linker needed to circularize the AFP. Details about this crucial dry lab stage are described on our Modeling Page | + | <p>A thorough dry lab analysis was performed to determine the appropriate linker needed to circularize the AFP. Details about this crucial dry lab stage are described on our <a href="https://2015.igem.org/Team:Queens_Canada/Modeling">Modeling Page</a>. After selecting the optimal linker (GAA), The AFP-linker-extein insert sequence was then designed to be compatible with the Golden Gate Assembly technique necessary for BBa_K1362000; BsaI cut sites were placed on the ends of the insert sequence to allow for successful insertion into Heidelberg’s BioBrick. The final designed insert is illustrated below in Figure 1.</p> |
<figure style="width:400px; float: right;"> | <figure style="width:400px; float: right;"> | ||
Line 87: | Line 87: | ||
<figure style="width: 400px; float: left; margin-top: 50px;"> | <figure style="width: 400px; float: left; margin-top: 50px;"> | ||
− | <img src="https://static.igem.org/mediawiki/2015/ | + | <img src="https://static.igem.org/mediawiki/2015/9/9d/Qqq_QGEM_rightcircAFPse.png" style="width: 400px;" /> |
<figcaption>Figure 4. <strong>SDS-PAGE of the size exclusion column fractions, depicting the purified circAFP (Fraction A9).</strong> </figcaption> | <figcaption>Figure 4. <strong>SDS-PAGE of the size exclusion column fractions, depicting the purified circAFP (Fraction A9).</strong> </figcaption> | ||
</figure> | </figure> | ||
Line 101: | Line 101: | ||
<figure style="float: right; width: 500px;"> | <figure style="float: right; width: 500px;"> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/b/ba/Qqq_QGEM_thgraph.png" style="float: right; width: 500px;"/> |
<figcaption>Figure 6. <strong>Bar graph of TH assay results, comparing wtAFP with our circAFP at various activity test conditions. </strong>Data shows that circAFP retains almost 80% of its antifreeze activity after being subjected to 90 <sup>o</sup>C . The wild-type AFP quickly loses its activity after exposure to such high temperatures. </figcaption> | <figcaption>Figure 6. <strong>Bar graph of TH assay results, comparing wtAFP with our circAFP at various activity test conditions. </strong>Data shows that circAFP retains almost 80% of its antifreeze activity after being subjected to 90 <sup>o</sup>C . The wild-type AFP quickly loses its activity after exposure to such high temperatures. </figcaption> | ||
</figure> | </figure> |
Latest revision as of 00:10, 18 September 2015